Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

1656158 Title: COMPOSITION PHARMACEUTIQUE LIQUIDE AQUEUSE DE POLYPEPTIDES DU FACTEUR VII

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
047390349
WO application number:
DK2004000537
Type:
European patent granted for BE
Status:
Deemed Void
Publication number:
1656158
WO publication number:
WO2005016365
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
12/08/2004
Grant date:
09/03/2016
EP publication date:
17/05/2006
WO publication date:
24/02/2005
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
09/03/2016
EP B1 publication date:
09/03/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
12/08/2024

Applicant

Name:
Novo Nordisk Health Care AG
Legal Form:
From:
09/03/2016
Address:
Thurgauerstrasse 36/38 8050 Zürich, Switzerland (CH)
To:

Inventor

1

Name:
JENSEN, Michael, Bech
Legal Form:
Address:
DK-3450 Aller d, Denmark (DK)

2

Name:
PETERSEN, Anders, Klarskov
Legal Form:
Address:
DK-2850 Närum, Denmark (DK)

3

Name:
BOWLER, Andrew, Neil
Legal Form:
Address:
DK-2820 Gentofte, Denmark (DK)

Priority

1

Priority patent number:
200301161
Priority date:
14/08/2003
Priority country:
Denmark (DK)

2

Priority patent number:
496443 P
Priority date:
20/08/2003
Priority country:
United States (US)

3

Priority patent number:
PCT/DK2004/000181
Priority date:
18/03/2004
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC or IDT classification:
A61K 38/36; A61K 47/16; A61K 38/48; A61K 31/17; A61K 47/02; A61K 47/18; A61K 47/42;

Publication

European Patent Bulletin

Issue number:
201610
Publication date:
09/03/2016
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/08/2016
Annual fee number:
13
Annual fee amount:
275 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type